314 related articles for article (PubMed ID: 15977647)
1. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.
McFadden K; Hamilton RL; Insalaco SJ; Lavine L; Al-Mateen M; Wang G; Wiley CA
J Neuropathol Exp Neurol; 2005 Jun; 64(6):545-52. PubMed ID: 15977647
[TBL] [Abstract][Full Text] [Related]
2. Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions.
Seilhean D; Takahashi J; El Hachimi KH; Fujigasaki H; Lebre AS; Biancalana V; Dürr A; Salachas F; Hogenhuis J; de Thé H; Hauw JJ; Meininger V; Brice A; Duyckaerts C
Acta Neuropathol; 2004 Jul; 108(1):81-7. PubMed ID: 15114487
[TBL] [Abstract][Full Text] [Related]
3. NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture.
Pountney DL; Raftery MJ; Chegini F; Blumbergs PC; Gai WP
Acta Neuropathol; 2008 Dec; 116(6):603-14. PubMed ID: 18836734
[TBL] [Abstract][Full Text] [Related]
4. SUMOylation substrates in neuronal intranuclear inclusion disease.
Takahashi-Fujigasaki J; Arai K; Funata N; Fujigasaki H
Neuropathol Appl Neurobiol; 2006 Feb; 32(1):92-100. PubMed ID: 16409557
[TBL] [Abstract][Full Text] [Related]
5. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
[TBL] [Abstract][Full Text] [Related]
6. Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease.
Sone J; Tanaka F; Koike H; Inukai A; Katsuno M; Yoshida M; Watanabe H; Sobue G
Neurology; 2011 Apr; 76(16):1372-6. PubMed ID: 21411744
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.
Mori F; Tanji K; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Kamitani T; Yoshida M; Wakabayashi K
Pathol Int; 2012 Jun; 62(6):407-11. PubMed ID: 22612509
[TBL] [Abstract][Full Text] [Related]
8. Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content.
Takahashi J; Fujigasaki H; Zander C; El Hachimi KH; Stevanin G; Dürr A; Lebre AS; Yvert G; Trottier Y; de Thé H; Hauw JJ; Duyckaerts C; Brice A
Brain; 2002 Jul; 125(Pt 7):1534-43. PubMed ID: 12077003
[TBL] [Abstract][Full Text] [Related]
9. Neuronal intranuclear inclusion disease in a horse.
Pumarola M; Vidal E; Trens JM; Serafín A; Marquez M; Ferrer I
Acta Neuropathol; 2005 Aug; 110(2):191-5. PubMed ID: 15971054
[TBL] [Abstract][Full Text] [Related]
10. Neuronal Intranuclear Inclusion Disease presenting as juvenile Parkinsonism.
Wiltshire KM; Dunham C; Reid S; Auer RN; Suchowersky O
Can J Neurol Sci; 2010 Mar; 37(2):213-8. PubMed ID: 20437931
[TBL] [Abstract][Full Text] [Related]
11. Neuropathological staging of spinocerebellar ataxia type 2 by semiquantitative 1C2-positive neuron typing. Nuclear translocation of cytoplasmic 1C2 underlies disease progression of spinocerebellar ataxia type 2.
Koyano S; Yagishita S; Kuroiwa Y; Tanaka F; Uchihara T
Brain Pathol; 2014 Nov; 24(6):599-606. PubMed ID: 24674145
[TBL] [Abstract][Full Text] [Related]
12. Neuronal intranuclear hyaline inclusion disease.
Takahashi-Fujigasaki J
Neuropathology; 2003 Dec; 23(4):351-9. PubMed ID: 14719553
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of neuronal intranuclear and cytoplasmic inclusions in Machado-Joseph disease.
Hayashi M; Kobayashi K; Furuta H
Psychiatry Clin Neurosci; 2003 Apr; 57(2):205-13. PubMed ID: 12667168
[TBL] [Abstract][Full Text] [Related]
14. Familial frontotemporal dementia with neuronal intranuclear inclusions is not a polyglutamine expansion disease.
Mackenzie IR; Butland SL; Devon RS; Dwosh E; Feldman H; Lindholm C; Neal SJ; Ouellette BF; Leavitt BR
BMC Neurol; 2006 Aug; 6():32. PubMed ID: 16945149
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy.
Lin WL; DeLucia MW; Dickson DW
Neurosci Lett; 2004 Jan; 354(2):99-102. PubMed ID: 14698448
[TBL] [Abstract][Full Text] [Related]
16. Pathological involvement of the motor neuron system and hippocampal formation in motor neuron disease-inclusion dementia.
Toyoshima Y; Piao YS; Tan CF; Morita M; Tanaka M; Oyanagi K; Okamoto K; Takahashi H
Acta Neuropathol; 2003 Jul; 106(1):50-6. PubMed ID: 12669241
[TBL] [Abstract][Full Text] [Related]
17. Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases.
Yamada M; Sato T; Shimohata T; Hayashi S; Igarashi S; Tsuji S; Takahashi H
Am J Pathol; 2001 Nov; 159(5):1785-95. PubMed ID: 11696439
[TBL] [Abstract][Full Text] [Related]
18. G protein-coupled receptor 26 immunoreactivity in intranuclear inclusions associated with polyglutamine and intranuclear inclusion body diseases.
Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K
Neuropathology; 2016 Feb; 36(1):50-5. PubMed ID: 26303144
[TBL] [Abstract][Full Text] [Related]
19. PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases.
Takahashi J; Fujigasaki H; Iwabuchi K; Bruni AC; Uchihara T; El Hachimi KH; Stevanin G; Dürr A; Lebre AS; Trottier Y; de Thé H; Tanaka J; Hauw JJ; Duyckaerts C; Brice A
Neurobiol Dis; 2003 Aug; 13(3):230-7. PubMed ID: 12901837
[TBL] [Abstract][Full Text] [Related]
20. SUMO on the road to neurodegeneration.
Dorval V; Fraser PE
Biochim Biophys Acta; 2007 Jun; 1773(6):694-706. PubMed ID: 17475350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
